SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (3482)1/5/2018 11:02:14 AM
From: Bladerunner17  Respond to of 3661
 
"Squlamine is finally DEAD, for real. After + 25 years. Did any fake-drug candidate leaved longer?"

CVM's Multikine.

Bladerunner



To: Miljenko Zuanic who wrote (3482)1/5/2018 12:18:17 PM
From: rkrw  Read Replies (1) | Respond to of 3661
 
Amazing and finally put them to sleep.
I wish they had disclosed the p-value. Seems it may well have been statistically significantly worse.



To: Miljenko Zuanic who wrote (3482)1/8/2018 12:31:50 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 3661
 
OHRP—Did any fake-drug candidate live longer?
Possibly Bavituximab. My post-mortem on Squalamine is at the bottom of investorshub.advfn.com .


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News